Despite representing only 4% of the world’s population, the United States accounts for over half of science Nobel Prizes ...

The president of the European Union’s executive branch, Ursula von der Leyen, faces a no-confidence vote this week linked in ...

J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.

The Cyprus issue, water scarcity issues and forest fires in the EU and developments in the Middle east will be among the topics discussed in the European Parliament’s (EP) plenary session held in ...

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

Robert "Bob" Cooper of the L.A. firm Gibson Dunn defended some of the country’s largest and most recognizable companies from ...

I didn’t set out to build a global innovation network spanning 45 countries. Here are four lessons from my journey.

In spite of its sustainable moat, Palantir Technologies is butting heads with historical headwinds that have a flawless track ...

Pfizer Inc. (NYSE: PFE) ranks among the best set-it-and-forget-it stocks to buy. On June 26, Pfizer Inc. (NYSE:PFE) declared ...

The combination of climate change and pathogen expansion could be fueling a surge in infectious diseases. GEN consulted ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...